Pfizer Inc. and partner BioNTech SE agreed to supply an additional 100 million doses of their Covid-19 vaccine to the US, as the country seeks to widen its immunization program and revive its economy.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply